Indaptus Therapeutics, Inc. INDP
INDP
Indaptus Therapeutics, Inc. SLXN
Silexion Therapeutics Ltd. REVB
Revelation Biosciences, Inc. PBM
Psyence Biomedical Ltd. NKGN
NKGen Biotech, Inc. Common Stock GTBP
GT Biopharma, Inc. ATXI
Avenue Therapeutics, Inc. PTIX
Protagenic Therapeutics, Inc. SLRX
Salarius Pharmaceuticals, Inc. LIPO
Lipella Pharmaceuticals Inc.
Indaptus Therapeutics, Inc. SLXN
Silexion Therapeutics Ltd. REVB
Revelation Biosciences, Inc. PBM
Psyence Biomedical Ltd. NKGN
NKGen Biotech, Inc. Common Stock GTBP
GT Biopharma, Inc. ATXI
Avenue Therapeutics, Inc. PTIX
Protagenic Therapeutics, Inc. SLRX
Salarius Pharmaceuticals, Inc. LIPO
Lipella Pharmaceuticals Inc.
Performance
| Periode | INDP | SLXN | REVB | PBM | NKGN | GTBP | ATXI | PTIX | SLRX | LIPO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -73.15 % | -79.64 % | -61.70 % | -80.92 % | -80.00 % | -74.63 % | 130.56 % | -65.17 % | -96.13 % | -87.81 % |
| YTD | -91.52 % | -91.66 % | -97.28 % | -93.76 % | -92.76 % | -73.68 % | -64.31 % | -82.94 % | -97.45 % | -93.67 % |
| 1Y | -91.84 % | -93.44 % | -94.09 % | -94.55 % | -92.22 % | -72.46 % | -61.73 % | -83.42 % | -97.17 % | -93.51 % |
| 3Y | -95.35 % | -99.05 % | -99.99 % | -99.98 % | -99.12 % | -97.70 % | -99.30 % | -95.05 % | -99.53 % | -99.44 % |
| 5Y | -99.55 % | -99.05 % | -100.00 % | -99.98 % | -99.12 % | -99.70 % | -99.99 % | -99.02 % | -99.97 % | -96.50 % |
| 10Y | -99.98 % | -99.05 % | -100.00 % | -99.98 % | -99.12 % | -100.00 % | -99.99 % | -99.02 % | -100.00 % | -96.50 % |
| Depuis le début | -99.98 % | -99.05 % | -100.00 % | -99.98 % | -99.12 % | -100.00 % | -99.99 % | -99.02 % | -100.00 % | -96.50 % |